Richard Zheng

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma”.

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma

Nature Communications(2022)10.1038/s41467-022-28801-y

N/A

2.1DataRank · unranked

100 citations

Timothy J. Purwin, McKenna Q. Glasheen, Signe Caksa, Manoela Tiago, Nicole A. Wilski +17 more

Twice‐Daily Doravirine Overcomes the Interaction Effect from Once‐Weekly Rifapentine and Isoniazid in Healthy Volunteers

Clinical and Translational Science(2020)10.1111/cts.12810

N/A

0DataRank · unranked

5 citations

Joseph Schaefer, Richard Zheng, Tingting Zhan, Walter K. Kraft, Edwin Lam

Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy (PAP-UP)

Research Square(2023)10.21203/rs.3.rs-2416574/v1

N/A

0DataRank · unranked

0 citations

Edwin Lam, Peter J. Altshuler, Madison Crutcher, Harish Lavu, Charles J. Yeo +4 more

Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer

HPB(2024)10.1016/j.hpb.2024.07.403

N/A

0DataRank · unranked

1 citations

Richard Zheng, Fabian M. Johnston, Jin He, William R. Burns, Christopher R. Shubert +3 more

Pharmacokinetics of apixaban in patients undergoing pancreaticoduodenectomy (PAP-UP)

International Journal of Clinical Pharmacology and Therapeutics(2024)10.5414/cp204502

N/A

0DataRank · unranked

1 citations

Edwin Lam, Peter J. Altshuler, Madison Crutcher, Harish Lavu, Charles J. Yeo +4 more